389 related articles for article (PubMed ID: 33294462)
1. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model.
Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F
J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway.
Li A; Yi B; Han H; Yang S; Hu Z; Zheng L; Wang J; Liao Q; Zhang H
Autophagy; 2022 Apr; 18(4):877-890. PubMed ID: 34432556
[TBL] [Abstract][Full Text] [Related]
3. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell.
Liu Y; Li L; Yi B; Hu ZX; Li AM; Yang C; Zheng L; Zhang H
Life Sci; 2019 Oct; 234():116755. PubMed ID: 31415769
[TBL] [Abstract][Full Text] [Related]
4. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
[TBL] [Abstract][Full Text] [Related]
5. VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway.
Guo J; Lu C; Zhang F; Yu H; Zhou M; He M; Wang C; Zhao Z; Liu Z
Cell Physiol Biochem; 2017; 43(1):39-51. PubMed ID: 28848172
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
[TBL] [Abstract][Full Text] [Related]
7. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
[TBL] [Abstract][Full Text] [Related]
11. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.
Riera M; Anguiano L; Clotet S; Roca-Ho H; Rebull M; Pascual J; Soler MJ
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F534-46. PubMed ID: 26697977
[TBL] [Abstract][Full Text] [Related]
12. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
Zhang Y; Deb DK; Kong J; Ning G; Wang Y; Li G; Chen Y; Zhang Z; Strugnell S; Sabbagh Y; Arbeeny C; Li YC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F791-801. PubMed ID: 19535571
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
14. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA
PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and proteinuria: a critical review of molecular bases and clinical experience.
Pérez-Gómez MV; Ortiz-Arduán A; Lorenzo-Sellares V
Nefrologia; 2013; 33(5):716-26. PubMed ID: 24089164
[TBL] [Abstract][Full Text] [Related]
17. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.
Tian W; Lei H; Guan R; Xu Y; Li H; Wang L; Yang B; Gao Z; Xin Z
Drug Des Devel Ther; 2015; 9():5147-57. PubMed ID: 26379427
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
19. Exogenous activated protein C inhibits the progression of diabetic nephropathy.
Gil-Bernabe P; D'Alessandro-Gabazza CN; Toda M; Boveda Ruiz D; Miyake Y; Suzuki T; Onishi Y; Morser J; Gabazza EC; Takei Y; Yano Y
J Thromb Haemost; 2012 Mar; 10(3):337-46. PubMed ID: 22236035
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
